QA: Neos Therapeutics Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001467652_2019_Neos_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001467652')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001467652, Neos Therapeutics Inc.

  xvar xval
0 AssetsCurrent 88,678,000
1 IntangibleAssetsNetIncludingGoodwill 14,616,000
2 PropertyPlantAndEquipmentNet 7,914,000
3 remainder_Assets 149,000
4 LiabilitiesCurrent 57,105,000
5 LiabilitiesNoncurrent 46,407,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 26,928,000
8 SellingGeneralAndAdministrativeExpense 13,915,000
9 ResearchAndDevelopmentExpense 8,508,000
10 remainder_Expenses 53,107,000
11 remainder_Revenues 49,988,000
12 remainder_NetIncome 795,000
13 remainder_ComprehensiveNetIncome 6,000
  yvar yval
0 Assets 111,357,000
1 Liabilities 103,512,000
2 Expenses 102,458,000
3 Revenues 49,988,000
4 StockholdersEquity 7,845,000
5 NetIncome -51,675,000
6 ComprehensiveNetIncome -51,672,000
7 BaseVar 184,058,000
8 EconomicCapitalRatio -0.355

Edgar->Model Mapping

Feature Distribution

Change over Time